Lenacapavir 300 mg, 463.5 mg/1.5 mL Suppliers & Bulk Manufacturers
Available Forms: Tablet / Injection
Available Strengths: 300 mg, 463.5 mg/1.5 mL
Reference Brands: Yeztugo (USA), Sunlenca (USA)
Category: Anti Viral
Lenacapavir is a Anti Viral product available as Tablet / Injection in strengths 300 mg, 463.5 mg/1.5 mL. It corresponds to the reference brands Yeztugo (USA), Sunlenca (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Lenacapavir is a long-acting antiretroviral medication used in the treatment of human immunodeficiency virus type 1 (HIV-1) infection, particularly in heavily treatment-experienced patients with multidrug-resistant virus where existing therapies are no longer effective or tolerated. It belongs to a novel class of medicines known as HIV-1 capsid inhibitors and works by targeting the viral capsid protein, disrupting multiple stages of the viral life cycle including assembly, transport, and replication. This unique mechanism makes it effective against strains resistant to other antiretroviral classes.
Lenacapavir is used in combination with other antiretroviral agents as part of an optimized background regimen. One of its key advantages is its long-acting profile, allowing extended dosing intervals that can improve adherence and treatment continuity. Clinical studies have shown strong antiviral activity, sustained viral load reduction, and a manageable safety profile in patients with limited treatment options. It is marketed under the brand name Sunlenca and developed by Gilead Sciences. Ongoing research is also exploring its role in long-acting preventive strategies and combination regimens for durable HIV management.
Lenacapavir — third party manufacturing & bulk supply
Lenacapavir 300 mg, 463.5 mg/1.5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Lenacapavir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Lenacapavir →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lenacapavir is used for treatment of multidrug-resistant HIV-1 infection and for HIV pre-exposure prophylaxis (PrEP) in approved regions.
It is a synthetic small-molecule HIV-1 capsid inhibitor formulated as lenacapavir sodium for oral and long-acting injectable use.
The trade names are Sunlenca and Yeztugo.
Lenacapavir is developed and marketed by Gilead Sciences.
The generic name is lenacapavir sodium.
The brand names are Sunlenca and Yeztugo.
It is manufactured by Gilead Sciences through globally approved manufacturing facilities compliant with US and EU regulatory standards.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Rimantadine Hydrochloride
Strength:
100 mg, 10 mg/mL
Form: Tablet / Syrup
Reference Brands: Flumadine (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
